MDNews - Mid Penn

Innovations 2018

Issue link: https://viewer.e-digitaledition.com/i/1045913

Contents of this Issue

Navigation

Page 5 of 15

T WO YE ARS AF TER ADOPTING THE WATCHMAN AND MITR ACLIP TECHNOLOGIES, WELL SPAN YORK HOSPITAL HA S BECOME A HIGH-VOLUME CENTER FOR STRUCTUR AL HE ART PROCEDURES, FOSTERING E XCELLENT OUTCOMES AND REMARK ABLE LE VEL S OF PATIENT SATISFACTION. CONDITIONS AFFECTING HEART valves and appendages can be extremely dif- ficult to treat, especially in patients who cannot tolerate surgery. Since initiating the Structural Heart Program in 2016, experienced WellSpan cardiologists can now offer hope for such patients, giving them effective treatment options that can often be implemented via minimally invasive procedures. WellSpan brings together the expertise of diagnostic cardiologists, inter ven- tional cardiologists, electrophysiologists, advanced practice clinicians and clinical staff to treat structural heart conditions. "The main reason for our success these past two years is the extensive collabora- tion among our working groups," says James Harvey, MD, MS, an interventional cardiologist and Director of the Structural Heart Program for WellSpan Health. " WellSpan Health's Structural Heart Program is cutting-edge, and the expertise of our providers is on a par with that of the physicians and surgeons anywhere a patient might go." — WILLIAM NICHOLSON, MD, DIRECTOR OF INTERVENTIONAL CARDIOLOGY AT WELLSPAN HEALTH The WATCHMAN left atrial appendage closure device BY JENNIFER WEBSTER WellSpan Health Unites Expertise with Technology to Successfully Treat Structural Heart Conditions ADVANCED CARE Dr. Ha r vey g ives a bird's-eye view of conditions the program addresses and the multidisciplina r y approach that makes its high rates of positive, durable outcomes possible. "One condition, atrial fibrillation, is among the most common problems we treat," he says. "Instead of contracting in a norma l cadence, the blood swirls, forming clots. These clots can break loose and travel throughout the body, putting patients at risk of stroke." "Cla ssica l ly, at r ia l f ibr i l lat ion i s treated by ablation therapy performed by an electrophysiologist," Dr. Harvey adds. " However, str uct ura l ca rdiol- og y — encompassing the nonsurgica l care of nonvascular parts of the heart — is now the fast-growing modality to treat this condition." With the WATCHM A N procedure, structura l ca rdiologists seek to reduce stroke risk for A Fib patients by pre- venting clots from forming in the lef t atria l appendage. W hile surgeons have had the option for decades to remove the appendage via open-hea r t surger y, t hat approach ca r r ied h ig h levels of risk for patients. Instead, ca rdiologists ty pica lly prescribed blood-thinners to ma nage stroke risk. The WATCHM A N provides a mini- ma l ly i nva sive mea n s of closi n g of f the lef t atria l appendage. A folded-up, c a ge -l i k e de v ic e i s i nt r o duc e d v i a femor a l vei n c a t he t er a c c e s s . T he surgeon crosses the interatria l septum t o ex pa nd t he WATCH M A N dev ice into the lef t atria l appendage, resulting in eventua l complete closure. Stroke r isk reduction is compa rable to t hat prov ided by wa r fa r i n , a ccord i n g t o WATCHM A N literature. Wel lSpa n ha s become the highest- volume WATCHM A N prog ra m on the Ea st Coa st , according to Dr. Ha r vey. It p e r for m s a b ou t 1 5 0 pr o c e du r e s a nnua l ly, w ith more tha n 98 percent resulting in successful impla ntation. T h e S t r u c t u r a l H e a r t P r o g r a m a lso treats patients who have mitra l reg urg itation, or backf low across the mitra l va lve, which ca n lead to hea r t fa i lure. In t he MitraClip procedure, a n inter ventiona l ca rdiolog ist inser ts a cl ippi n g dev ice t h roug h a femora l PHOTO COURTESY OF BOSTON SCIENTIFIC 0 6 0 6❱❱❱❱❱ H I G H - L E V E L H E A R T C A R E

Articles in this issue

Archives of this issue

view archives of MDNews - Mid Penn - Innovations 2018